On one hand, a spontaneous or engineered reduction in insulin signaling can extend lifespan in model organisms [11, 12], yet peripheral insulin resistance in rodents and humans, as classically defined by an impaired ability of insulin to regulate glucose, is a salient feature of visceral obesity, type 2 diabetes (T2D), and aging [11]. This evidence concerns the gene INS and Insulin resistance.